Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

CVS Health’s PBM might influence which drugs are promoted and covered, potentially preferring Cordavis’ products over others. The result would stifle market competition. Patient steerage to ...

which is the PBM’s specialty pharmacy. What CVS Caremark and Express Scripts are doing is (mostly) steering patients to their preferred products, which aren’t necessarily the least expensive.

The health portion contains pharmaceutical benefit manager (PBM) industry reforms, extensions of Medicare telehealth flexibilities, reauthorizations of legislation to prevent pandemics and address ...

“PBM tactics inflate American’s prescription drug costs, force pharmacy closures, and block access to Americans’ pharmacies of choice. The work done by Congress in the 118th Congress and in ...

Now that the election is over and Congress is in its lame duck session, one of the most pressing issues is reforming the abusive PBM industry. PBMs — or pharmacy benefit managers — are the ...

Banning PBM spread pricing in Medicaid-managed care ... We sell different types of products and services to both investment professionals and individual investors. These products and services ...